Search for the latest oncology news by tumour type
A dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland…
For the first time, researchers have found that lung cancer patients who have a combination…
Ovarian cancer (OC) remains the deadliest gynaecologic malignancy, with platinum-based chemotherapies such as carboplatin serving…
On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix with lenalidomide and rituximab…
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research,…
There may be hopeful news ahead for families with a history of breast and ovarian…
A new study from the University of Michigan Rogel Cancer Center, USA, published in Science,…
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification…
A fixed-duration regimen of acalabrutinib in combination with venetoclax, with or without obinutuzumab, has been…
Cancer Research UK-funded scientists at The Institute of Cancer Research, London, UK, have discovered what…